Clinical Trial Update: Efficacy of Radiation Therapy and Transarterial Chemoembolization (TACE) to Treat Hepatocellular Carcinoma (HCC) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating radiation therapy in combination with transarterial chemoembolization for hepatocellular carcinoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Transarterial chemoembolization (TACE)

Snippet

Sponsor: Asan Medical Center | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: WITHDRAWN